A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

United States

Woodholme Gastroenterology Associates, Glen Burnie, Maryland

Tyler Research Institute, LLC, Tyler, Texas

China

Chongqing General Hospital, Chongqing, Chongqing Municipality

The First Affiliated Hospital of Sun Yat-sen University, Guangdong, Guangdong

The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality

Czechia

Hepato-Gastroenterologie HK s.r.o., Hradec Králové

Hungary

Pannonia Maganorvosi Centrum, Budapest

Netherlands

St. Antonius Ziekenhuis, Tilburg, North Brabant

Poland

Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii Specj, Torun, Kuyavian-Pomeranian Voivodeship

Centrum Medyczne MedykSp. z o.o. Sp. K., Lublin

Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin

WIP Warsaw IBD Point Profesor Kierkus, Warsaw

Slovakia

Endomed, Košice

South Korea

Inje University Haeundae Paik Hospital, Haeundae, Busan Gwangyeogsi

Yonsei University Wonju Severance Christian Hospital, Wŏnju, Gangwon-do